HRT FINANCIAL LP

Position in CGC — Canopy Growth Corp

CIK 1475597 NEW YORK, NY

Position in CGC

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$679,326

+$377,569 QoQ

Shares Held

715,081

+124.9% QoQ

Ownership

0.169%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#10

of 212 holders

Holding Since

Dec 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HRT FINANCIAL LP holds $132,018,496 across 28 Drug Manufacturers - Specialty & Generic names. CGC ranks #15 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	98,864	$53,567,481
2	ZTS	Zoetis Inc.	241,369	$17,344,776
3	BCRX	Biocryst Pharmaceuticals Inc	1,081,523	$10,815,230
4	TEVA	Teva Pharmaceutical Industries Ltd	295,918	$10,025,701
5	AMPH	Amphastar Pharmaceuticals, Inc.	387,530	$7,820,355
6	HLN	Haleon plc	682,281	$6,365,681
7	ANIP	Ani Pharmaceuticals Inc	63,008	$5,215,802
8	TAK	Takeda Pharmaceutical Co Ltd	278,706	$4,467,657

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$679,326	715,081	+124.9%	Shares	Defined	2026-08-14
2026-03-31	$301,757	317,974	-10.6%	Shares	Defined	2026-05-14
2025-12-31	$405,268	355,499	-71.4%	Shares	Defined	2026-02-12
2025-09-30	$1,814,883	1,243,071	+180.0%	Shares	Defined	2025-11-14
2025-06-30	$541,604	443,938	+848.4%	Shares	Defined	2025-08-14
2023-06-30	$18,161	46,809	-95.5%	Shares	Defined	2023-08-11
2023-03-31	$1,813,651	1,036,372	+2989.7%	Shares	Defined	2023-05-12
2022-12-31	$77,484	33,543	+62.9%	Shares	Defined	2023-02-10
2022-09-30	$56,213	20,591	-48.0%	Shares	Defined	2022-11-14
2021-09-30	$548,537	39,577	+0.8%	Shares	Defined	2021-11-15
2021-03-31	$1,257,818	39,270	+320.0%	Shares	Defined	2021-05-17
2020-12-31	$230,384	9,350	—	Shares	Defined	2021-02-16
No filing history on record for this holder in this stock.